Aligos Therapeutics Inc (ALGS)
19.46
+0.01
(+0.05%)
USD |
NASDAQ |
Nov 14, 16:00
19.40
-0.06
(-0.31%)
After-Hours: 20:00
Aligos Therapeutics Total Liabilities (Quarterly): 38.33M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.33M |
| June 30, 2024 | 41.58M |
| March 31, 2024 | 68.11M |
| December 31, 2023 | 59.45M |
| September 30, 2023 | 31.03M |
| June 30, 2023 | 36.50M |
| March 31, 2023 | 36.99M |
| December 31, 2022 | 42.79M |
| September 30, 2022 | 42.06M |
| June 30, 2022 | 45.54M |
| Date | Value |
|---|---|
| March 31, 2022 | 57.58M |
| December 31, 2021 | 50.64M |
| September 30, 2021 | 46.06M |
| June 30, 2021 | 42.99M |
| March 31, 2021 | 39.32M |
| December 31, 2020 | 45.26M |
| September 30, 2020 | 228.85M |
| June 30, 2020 | 26.72M |
| December 31, 2019 | 211.41M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
26.72M
Minimum
Jun 2020
228.85M
Maximum
Sep 2020
62.69M
Average
42.99M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Haemonetics Corp | 1.646B |
| Pliant Therapeutics Inc | 99.84M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.43M |
| Shareholders Equity (Quarterly) | 50.10M |
| Current Ratio | 3.809 |